Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 26 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
NCT04322383
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06965114
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- NCI - Center for Cancer Research Bethesda, Maryland, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States
NCT04815356
- Conditions
- Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT00412594
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06561360
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
NCT04775745
- Conditions
- Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
- Locations
-
- Duke Univerisity Durham, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State University Columbus, Ohio, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
Recruiting
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
NCT06340737
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT06781515
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
NCT02131753
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Community based hemato-oncology medical office Ansbach, Germany
- Community based hemato-oncology medical office Aschaffenburg, Germany
- Rhön-Saale-Klinik gGmbH Bad Neustadt an der Saale, Germany
- Community based hemato-oncology medical office Berlin, Germany
Enrolling by Invitation
Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant
NCT07690761
- Conditions
- Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +9 more
- Locations
-
- Bnai Zion Haifa, Israel
NCT07679919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States
Completed
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
NCT05388123
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Scripps Cancer Center La Jolla, California, United States
NCT01711632
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Scripps Clinic La Jolla, California, United States
- Northwestern University Evanston, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
LMB-2 to Treat Hairy Cell Leukemia
NCT00321555
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT03010358
- Conditions
- Anemia, B-Cell Prolymphocytic Leukemia, Chronic Disease, +36 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT00586924
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Research Site Stanford, California, United States
- Research Site Chicago, Illinois, United States
- Research Site Bethesda, Maryland, United States
- Research Site Lodz, Poland
NCT00898079
- Conditions
- Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +43 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT01720758
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
NCT00001567
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hematologic Neoplasms, +10 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States